Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsUkena, Sya N
Westendorf, Astrid M
MetadataShow full item record
AbstractBACKGROUND: Probiotics are proposed to positively modulate the intestinal epithelial barrier formed by intestinal epithelial cells (IECs) and intercellular junctions. Disruption of this border alters paracellular permeability and is a key mechanism for the development of enteric infections and inflammatory bowel diseases (IBDs). METHODOLOGY AND PRINCIPAL FINDINGS: To study the in vivo effect of probiotic Escherichia coli Nissle 1917 (EcN) on the stabilization of the intestinal barrier under healthy conditions, germfree mice were colonized with EcN or K12 E. coli strain MG1655. IECs were isolated and analyzed for gene and protein expression of the tight junction molecules ZO-1 and ZO-2. Then, in order to analyze beneficial effects of EcN under inflammatory conditions, the probiotic was orally administered to BALB/c mice with acute dextran sodium sulfate (DSS) induced colitis. Colonization of gnotobiotic mice with EcN resulted in an up-regulation of ZO-1 in IECs at both mRNA and protein levels. EcN administration to DSS-treated mice reduced the loss of body weight and colon shortening. In addition, infiltration of the colon with leukocytes was ameliorated in EcN inoculated mice. Acute DSS colitis did not result in an anion secretory defect, but abrogated the sodium absorptive function of the mucosa. Additionally, intestinal barrier function was severely affected as evidenced by a strong increase in the mucosal uptake of Evans blue in vivo. Concomitant administration of EcN to DSS treated animals resulted in a significant protection against intestinal barrier dysfunction and IECs isolated from these mice exhibited a more pronounced expression of ZO-1. CONCLUSION AND SIGNIFICANCE: This study convincingly demonstrates that probiotic EcN is able to mediate up-regulation of ZO-1 expression in murine IECs and confer protection from the DSS colitis-associated increase in mucosal permeability to luminal substances.
CitationProbiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. 2007, 2 (12):e1308 PLoS ONE
AffiliationDepartment of Mucosal Immunity, Helmholtz Centre for Infection Research, Braunschweig, Germany.
The following license files are associated with this item:
- Beneficial effects resulting from oral administration of Escherichia coli Nissle 1917 on a chronic colitis model.
- Authors: Souza ELS, Campos CLV, Reis DC, Cassali GD, Generoso SV, Cardoso VN, Azevedo V, Medeiros JD, Fernandes GR, Nicoli JR, Martins FS
- Issue date: 2020 Dec 2
- Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model.
- Authors: Souza ÉL, Elian SD, Paula LM, Garcia CC, Vieira AT, Teixeira MM, Arantes RM, Nicoli JR, Martins FS
- Issue date: 2016 Mar
- Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice.
- Authors: Liang M, Zhang J, Yang Y, Xia Y, Liu L, Liu L, Wang Q, Gao X
- Issue date: 2022 Nov 9
- Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.
- Authors: Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA
- Issue date: 2007 Mar
- Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
- Authors: Alvarez CS, Giménez R, Cañas MA, Vera R, Díaz-Garrido N, Badia J, Baldomà L
- Issue date: 2019 Jul 17